- Motley Fool•11 hours ago
Good news for the company's clinical-stage candidate keeps pouring in.
- Motley Fool•16 hours ago
These three stocks offer explosive upside potential.
- Business Wire•21 hours ago
Omeros Announces OMS721 Presentation at Annual Meeting of the European Society for Blood and Marrow Transplantation
Omeros Corporation today announced presentation of a case report describing resolution of hematopoietic stem cell transplant-associated thrombotic microangiopathy in a dialysis- and transfusion-dependent adolescent girl who was treated with OMS721 under a compassionate-use protocol.
OMER : Summary for Omeros Corporation - Yahoo Finance
Omeros Corporation (OMER)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||13.95 x 1000|
|Ask||15.97 x 600|
|Day's Range||12.51 - 16.37|
|52 Week Range||7.20 - 16.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.55|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|